(Q46166532)

20 December 2017

title

The pathogenesis and modulation of the post-treatment reactive encephalopathy in a mouse model of Human African Trypanosomiasis (English)

1 reference

20 December 2017

main subject

trypanosomiasis

0 references

African trypanosomiasis

0 references

author name string

P G Kennedy

series ordinal

1

1 reference

20 December 2017

publication date

1 December 1999

1 reference

20 December 2017

Journal of Neuroimmunology

published in

1 reference

20 December 2017

volume

100

1 reference

20 December 2017

issue

1-2

1 reference

20 December 2017

page(s)

36-41

1 reference

20 December 2017

Human African trypanosomiasis (T.b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Human and rodent interferon-gamma as a growth factor for Trypanosoma brucei.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Necessity of antibody response in the treatment of African trypanosomiasis with alpha-difluoromethylornithine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Substance P receptor antagonist inhibits murine IgM expression in developing schistosome granulomas by blocking the terminal differentiation of intragranuloma B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Increased levels of antibodies to IFN-gamma in human and experimental African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Interleukin-6 secretion from human astrocytoma cells induced by substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Immunopathology in central nervous system human African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Immunopathology of experimental African sleeping sickness: detection of cytokine mRNA in the brains of Trypanosoma brucei brucei-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Subcurative chemotherapy and fatal post-treatment reactive encephalopathies in African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Correlation of autoantibody titres with central nervous system pathology in experimental African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

The use of azathioprine to ameliorate post-treatment encephalopathy associated with African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Chemotherapy of Trypanosoma brucei infection of the central nervous system: the use of a rapid chemotherapeutic regimen and the development of post-treatment encephalopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

A substance P antagonist, RP-67,580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Stimulation of human B lymphocyte differentiation by the neuropeptides substance P and neurokinin A

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Effect of neuropeptides on production of inflammatory cytokines by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Substance P stimulates IL-1 production by astrocytes via intracellular calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Neurobiology of sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Immunopathological and chemotherapeutic studies in experimental trypanosomiasis with special reference to the heart and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

Substance P receptors in primary cultures of cortical astrocytes from the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900196-4

7 January 2021

10.1016/S0165-5728(99)00196-4

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017